From: The Global Fund's resource allocation decisions for HIV programmes: addressing those in need
Variables | GNI per capita, 2009 | HIV prevalence 14-45, 2009 | Prevalence in MARPs |
---|---|---|---|
All countries-recipients of the Global Fund HIV programmes (n = 145) | |||
Annual median per capita funding for HIV | 0.282 (1.415)* | 0.313 (1.937)*** | 0.370 (2.118)*** |
Low-income countries (n = 40) | |||
Annual median per capita funding for HIV | NS | 0.483 (1.795)** | 0.338 (-0.047)* |
Upper-middle-income countries (n = 37) | |||
Annual median per capita funding for HIV | NS | 0.425 (1.380)*** | 0.820 (2.412)*** |
Concentrated epidemics (n = 52) | |||
Annual median per capita funding for HIV | 0.121 (2.244)** | 0.311 (1.840)* | 0.580 (1.205)* |
Generalized epidemics (n = 48) | |||
Annual median per capita funding for HIV | 0.427 (2.467)*** | 0.250 (1.322)** | 0.480 (1.783)** |
Sub-Saharan Africa region (n = 43) | |||
Annual median per capita funding for HIV | NS | 0.355 (2.073) | 0.118 (0.959) |
Eastern Europe and Central Asia region (n = 24) | |||
Annual median per capita funding for HIV | 0.621 (-1.446)* | 0.430 (2.104)** | 0.625 (2.1943)*** |
Latin America and Caribbean region (n = 30) | |||
Annual median per capita funding for HIV | NS | 0.530 (1.775)* | 0.748 (2.430)*** |
Asia region (n = 27) | |||
Annual median per capita funding for HIV | NS | 0.350 (1.840) | 0.348 (1.271) |